A detailed history of Bill Few Associates, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Bill Few Associates, Inc. holds 1,646 shares of AMGN stock, worth $533,896. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,646
Previous 1,639 0.43%
Holding current value
$533,896
Previous $466,000 10.3%
% of portfolio
0.2%
Previous 0.19%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$262.75 - $319.31 $1,839 - $2,235
7 Added 0.43%
1,646 $514,000
Q1 2024

Apr 18, 2024

BUY
$268.87 - $324.56 $1,613 - $1,947
6 Added 0.37%
1,639 $466,000
Q3 2022

Oct 13, 2022

BUY
$224.46 - $253.15 $11,223 - $12,657
50 Added 3.16%
1,633 $368,000
Q2 2022

Jul 26, 2022

SELL
$230.71 - $256.74 $9,228 - $10,269
-40 Reduced 2.46%
1,583 $385,000
Q1 2022

Apr 27, 2022

SELL
$219.27 - $242.57 $219 - $242
-1 Reduced 0.06%
1,623 $392,000
Q4 2021

Mar 04, 2022

BUY
$198.88 - $227.6 $322,981 - $369,622
1,624 New
1,624 $365,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $174B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bill Few Associates, Inc. Portfolio

Follow Bill Few Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bill Few Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bill Few Associates, Inc. with notifications on news.